You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Transient Receptor Potential Vanilloid 1 (TRPV-1) receptor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Participants Trial in Brussels (Vepdegestrant, Carbamazepine)

Not yet recruiting
  • Healthy Participants
  • Brussels, Belgium
    Pfizer Clinical Research Unit - Brussels
Aug 15, 2023

ER+ Breast Cancer Trial in Sherbrooke (4FMFES-PET)

Recruiting
  • ER+ Breast Cancer
  • 4FMFES-PET
  • Sherbrooke, Quebec, Canada
    Université deSherbrooke
Jul 18, 2022

Healthy Trial (ARV-471, Itraconazole)

Not yet recruiting
  • Healthy
  • (no location specified)
Sep 8, 2022

Opioid Analgesic Adverse Reaction Trial in Taiyuan (Esketamine, Sulfentanil or/and Remifentanil)

Recruiting
  • Opioid Analgesic Adverse Reaction
  • Esketamine, Sulfentanil or/and Remifentanil
  • Taiyuan, Shanxi, China
    Zheng Guo
Apr 18, 2022

Interstitial Cystitis Trial in Saint Louis (Questionnaires, Collection of Blood samples)

Completed
  • Interstitial Cystitis
  • Questionnaires
  • Collection of Blood samples
  • Saint Louis, Missouri
    Saint Louis University Department of Obstetrics, Gynecology, and
Jul 22, 2021

COVID-19, Cardiovascular Diseases Trial in Brazil, Canada, Mexico (Angiotensin converting enzyme inhibitor, Angiotensin II

Recruiting
  • COVID-19
  • Cardiovascular Diseases
  • Angiotensin converting enzyme inhibitor
  • Angiotensin II Receptor Blockers
  • Maceio, Alagoas, Brazil
  • +30 more
Jan 13, 2023

Irritable Bowel Syndrome Trial in Roma (palmithoylethanolamide/polydatin, )

Recruiting
  • Irritable Bowel Syndrome
  • palmithoylethanolamide/polydatin
  • placebo
  • Roma, Rome, Italy
    Prof Giovanni Di Nardo
May 10, 2023

Oral Squamous Cell Carcinoma Trial in New York (Chemical sensitivity, Mechanical sensitivity)

Recruiting
  • Oral Squamous Cell Carcinoma
  • Chemical sensitivity
  • Mechanical sensitivity
  • New York, New York
    New York University College of Dentistry
Sep 26, 2022

Heart Failure Trial in Boston, Cincinnati, Providence (probenecid, Placebo)

Recruiting
  • Heart Failure
  • Boston, Massachusetts
  • +2 more
Sep 14, 2022

Activation of Sphingosine-1-phosphate to S1P1 Receptor Subtype

Completed
  • Endometriosis
    • Saint Louis, Missouri
      SSM St. Mary's
    Sep 9, 2020

    Pain Trial in Vienna (Room temperature, Cold temperature, Lidocain)

    Not yet recruiting
    • Pain
    • Room temperature
    • +6 more
    • Vienna, Austria
      Medical University of Vienna
    Jul 6, 2023

    Obesity Trial in Guadalajara (Olvanil, Placebo)

    Recruiting
    • Obesity
    • Olvanil
    • Placebo
    • Guadalajara, Jaliscco, Mexico
    • +1 more
    May 10, 2023

    Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

    Not yet recruiting
    • Pericarditis
    • IL1RA Antibody Assay
    • suPAR Testing
    • Homburg, Germany
    • +8 more
    Jun 22, 2023

    Vulvodynia: Identification of Potential Relevant Biomarkers

    Completed
    • Vulvodynia
      • Saint Louis, Missouri
      • +1 more
      Aug 26, 2020

      Inflammation; Skin, Psoriasis Trial in Brest (skin biopsy and blood sampling)

      Recruiting
      • Inflammation; Skin
      • Psoriasis
      • skin biopsy and blood sampling
      • Brest, France
        TALAGAS
      Dec 29, 2021

      Sleep Disorder, Healthy Trial in Baltimore (Sleep Fragmentation, Within-Subject test of blinded study medication (stimulant,

      Recruiting
      • Sleep Disorder
      • Healthy
      • Sleep Fragmentation
      • +3 more
      • Baltimore, Maryland
        Johns Hopkins School of Medicine
      Nov 14, 2022

      Roles of Some Non-classic Biomarkers in Pediatric Pneumonia

      Not yet recruiting
      • Pneumonia in Children
        • (no location specified)
        Jan 25, 2023

        Leukemia, Myeloid, Acute Trial in United States (VCAR33)

        Not yet recruiting
        • Leukemia, Myeloid, Acute
        • VCAR33
        • La Jolla, California
        • +9 more
        Aug 14, 2023

        Non-hodgkin Lymphoma,B Cell Trial in Beijing (Autologous CD19-STAR-T cell, Fludarabine, Cyclophosphamide)

        Recruiting
        • Non-hodgkin Lymphoma,B Cell
        • Autologous CD19-STAR-T cell
        • +2 more
        • Beijing, Beijing, China
        • +1 more
        Nov 21, 2022

        Osteoporosis, Postmenopausal, Diabetes, Type 2 Trial in Jackson (GLP-1 receptor agonist)

        Recruiting
        • Osteoporosis, Postmenopausal
        • Diabetes Mellitus, Type 2
        • GLP-1 receptor agonist
        • Jackson, Mississippi
          University of Mississippi Medical Center
        Aug 5, 2022

        Melanoma (Skin), Metastatic Melanoma, Melanoma Stage IV Trial in Iowa City, Rochester, Madison ([212Pb]VMT01)

        Not yet recruiting
        • Melanoma (Skin)
        • +5 more
        • Iowa City, Iowa
        • +2 more
        Dec 8, 2022

        Renin Angiotensin Aldosterone System Genetic Polymorphism on

        Recruiting
        • Myocardial Infarction
          • Cairo, Egypt
            Ain Shams University
          May 16, 2023

          Therapy After Kidney Transplantation

          Recruiting
          • Transplantation Infection
          • Kidney Diseases
            • Odense, DK, Denmark
              Odense University Hospital
            Nov 5, 2021

            Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura

            Not yet recruiting
            • ITP - Immune Thrombocytopenia
            • eltrombopag and romiplastim
            • (no location specified)
            Nov 16, 2023

            Bilateral Breast Carcinoma, Breast Inflammatory Carcinoma, Stage IB Breast Cancer AJCC v7 Trial in United States (drug, other,

            Active, not recruiting
            • Bilateral Breast Carcinoma
            • +11 more
            • Scottsdale, Arizona
            • +11 more
            Jan 12, 2023